Frankfurt is the venue for the Global Generics & Biosimilars Awards 2025, with entries now open for our annual celebration of the off-patent industry’s leading accomplishments, ahead of a prizegiving ceremony that will take place on Wednesday 29 October, during CPhI Worldwide week.
Now in their twelfth year, the awards – which are free to enter and attend, with our awards ceremony taking place at the Radisson Blu Hotel, Frankfurt – celebrate the greatest achievements across the generics, biosimilars and value added medicines industries.
Entries are open until Friday 1 August 2025 and can cover any activities undertaken between 1 August 2024 and 31 July 2025. As in previous years, our categories include:
- Company of the Year
- Regional Companies of the Year – Americas, APAC and EMEA
- Acquisition of the Year
- Leader of the Year
- Value Added Medicine Initiative of the Year
- Business Development of the Year
- API Supplier of the Year
- Biosimilar Initiative of the Year
- Regulatory Achievement of the Year
- Corporate Social Responsibility (CSR) Initiative of the Year
- Industry Partner of the Year
- Campaign of the Year
Our CSR Initiative of the Year award will once again be supported by longtime associate International Health Partners.
“We can’t wait to be back in Frankfurt, in an impressive new venue, to celebrate the greatest achievements seen this year by the global generics, biosimilars and value added medicines industry,” commented Dave Wallace, executive editor of Generics Bulletin.
“With the off-patent industry playing an increasingly important role in contributing valuable treatments to healthcare systems worldwide at affordable prices, while also broadening access to essential medicines, we’re proud to be shining the spotlight on the companies and individuals that are leading these achievements.”
The Global Generics & Biosimilars Awards prides itself on its independence, with winners chosen solely on merit and acknowledged as the most deserving of recognition for their unique achievements.
All submissions are reviewed by an independent panel of expert judges, who have been selected on the basis of their industry knowledge and impartiality.
For a full list of the awards categories, submissions criteria, how to attend and other information, go here.
To enquire about sponsorship opportunities, please e-mail George.Wilkins@citeline.com
And to register interest in attending the Global Generics & Biosimilars Awards 2025, to receive the latest updates and for any further details, please e-mail Natalia.Kay@citeline.com